The cell line is not validated yet.
AOUMEYi004-A
General
iPSC Line |
|
| hPSCreg name | AOUMEYi004-A |
| Cite as: | AOUMEYi004-A |
| iPSC line type | Human induced pluripotent stem cell (hiPSC) |
| Similar iPSC lines | No similar lines found. |
| Last update | 18th June 2026 |
| User feedback | |
Provider |
|
| Generator | Meyer Children's Hospital IRCCS (AOUMEY) |
| Owner | Meyer Children's Hospital IRCCS (AOUMEY) |
| Distributors | |
| Derivation country | Italy |
External iPSC Databases |
|
| BioSamples | SAMEA120580148 |
General iPSC Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Donor Information
General Donor Information |
|
| Sex | male |
| Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
Karyotyping (Donor) |
|
| Has the donor karyotype been analysed? |
Yes
46, XY
Karyotyping method:
qPCR-based genetic analysis
|
External Databases (Donor) |
|
| BioSamples | SAMEA122790719 |
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| * Does consent expressly prevent the derivation of pluripotent stem cells? | No |
| * Does consent pertain to a specific research project? | No |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | Yes |
| How may genetic information associated with the cell line be accessed? | Controlled Access |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | Comitato Etico Regionale per la Sperimentazione Clinica della Regione Toscana” (AREA VASTA CENTRO) |
| Approval number | 16774_bio |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
iPSC Derivation
General |
|
| Source cell type |
A connective-tissue cell of mesenchymal origin that secretes proteins and especially molecular collagen from which the extracellular fibrillar matrix of connective tissue forms.
|
| Source cell origin | |
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | ReproRNA™-OKSGM |
| Is reprogramming vector detectable? |
Yes |
| Methods used |
RT-PCR
|
Vector free reprogramming |
|
| Type of used vector free reprogramming factor(s) |
mRNA
|
Other |
|
| Derived under xeno-free conditions |
Yes |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
iPSC Culture Conditions
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method | Mechanically |
| O2 Concentration | 18 % |
| CO2 Concentration | 5 % |
| Medium |
mTeSR™ Plus
|
| Has Rock inhibitor (Y27632) been used at passage previously with this iPSC line? | Yes |
| Has Rock inhibitor (Y27632) been used at cryo previously with this iPSC line? | Yes |
| Has Rock inhibitor (Y27632) been used at thaw previously with this iPSC line? | Yes |
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| NANOG |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| SOX2 |
Yes |
|
||||
| KLF transcription factor 4 |
Yes |
|
Morphology pictures
Method documentation
NANOG Man 488.tif
Immunofluorescence
OCT3-4 Man 564.tif
Immunofluorescence
SOX2 Man 627.tif
Immunofluorescence
Differentiation Potency
In vitro directed differentiation
| Marker | Expressed |
| SRY-box transcription factor 17 |
Yes |
| GATA binding protein 4 |
Yes |
In vitro directed differentiation
| Marker | Expressed |
| T-box transcription factor T |
Yes |
| EOMES |
Yes |
In vitro directed differentiation
| Marker | Expressed |
| SRY-box transcription factor 1 |
Yes |
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
46, XY
Passage number: 12
|
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.